Search results for "small cell lung cancer treatment"

Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an Orphan Drug for the treatment...
Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters

Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters

Lung cancer is the second most commonly diagnosed cancer in South Korea and the leading cause of cancer mortality, making it one of the country's...
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026

Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026

Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...
Severe Lung Complications Drop Below 10% for Early Lung Cancer Patients with IPF Treated with Proton Therapy

Severe Lung Complications Drop Below 10% for Early Lung Cancer Patients with IPF Treated with Proton Therapy

For patients diagnosed with idiopathic pulmonary fibrosis —a chronic disease in which lung tissue inexplicably becomes...
Yonsei Cancer Center Expands Carbon-Ion Therapy to Head and Neck Cancers, Sarcomas, and Recurrent Rectal Cancers

Yonsei Cancer Center Expands Carbon-Ion Therapy to Head and Neck Cancers, Sarcomas, and Recurrent Rectal Cancers

For patients facing cancers that are anatomically difficult to operate on or resistant to conventional radiation—as...
Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and...
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following...
Beyond the 'Miracle Cure' Myth: Why Early Detection Remains Our Strongest Weapon Against Cancer

Beyond the 'Miracle Cure' Myth: Why Early Detection Remains Our Strongest Weapon Against Cancer

The number of cancer diagnoses in South Korea is rising sharply, and warnings about growing case counts are no longer a...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...